Literature DB >> 1450945

HIV-1 envelope protein evokes intracellular calcium oscillations in rat hippocampal neurons.

T M Lo1, C J Fallert, T M Piser, S A Thayer.   

Abstract

Treatment of single rat hippocampal neurons with 200 pM recombinant HIV-1 envelope glycoprotein, gp120, resulted in large increases in the intracellular free calcium concentration ([Ca2+]i) as measured with indo-1-based microfluorimetry. Three patterns of [Ca2+]i increases were observed: in one pattern the [Ca2+]i rose rapidly and transiently as a single peak, in a second pattern gp120 induced [Ca2+]i oscillations that subsided when the protein was removed, and in a third pattern the oscillations continued long after washout of gp120. Both single peak and oscillatory [Ca2+]i increases were completely blocked by the Ca2+ channel blocker nitrendipine (1 microM). The sustained oscillatory responses were also blocked completely and reversibly by the N-methyl-D-aspartate (NMDA) receptor antagonist CGS19755 (10 microM) and the Na+ channel blocker tetrodotoxin (1 microM). Complete block by antagonists of Ca2+, Na+, and NMDA-gated ion channels suggests that at least two cells are required to maintain the [Ca2+]i oscillations. We hypothesize that gp120 acts as an excitotoxin by increasing synaptic activity in the network of neurons established in primary culture.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1450945     DOI: 10.1016/0006-8993(92)91125-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

1.  Induction of cell-cycle regulators in simian immunodeficiency virus encephalitis.

Authors:  K L Jordan-Sciutto; G Wang; M Murphy-Corb; C A Wiley
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Endocrine modulation of the neurotoxicity of gp120: implications for AIDS-related dementia complex.

Authors:  S Brooke; R Chan; S Howard; R Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  Functional CXCR4 receptor development parallels sensitivity to HIV-1 gp120 in cultured rat astroglial cells but not in cultured rat cortical neurons.

Authors:  Hubertus Köller; Heiner Schaal; Claudia Rosenbaum; Margarete Czardybon; Hans Jürgen Von Giesen; Hans Werner Müller; Gabriele Arendt
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

4.  The chemokine CXCL12 and the HIV-1 envelope protein gp120 regulate spontaneous activity of Cajal-Retzius cells in opposite directions.

Authors:  Ivan Marchionni; Michael Beaumont; Gianmaria Maccaferri
Journal:  J Physiol       Date:  2012-04-02       Impact factor: 5.182

5.  Neuronal glycolytic pathway impairment induced by HIV envelope glycoprotein gp120.

Authors:  A L Vignoli; I Martini; K G Haglid; L Silvestroni; G Augusti-Tocco; S Biagioni
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

6.  Simulation of the diffusion and reaction of endogenously produced nitric oxide.

Authors:  J R Lancaster
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

7.  Distinct modifications in Kv2.1 channel via chemokine receptor CXCR4 regulate neuronal survival-death dynamics.

Authors:  Andrew J Shepherd; Lipin Loo; Raeesa P Gupte; Aaron D Mickle; Durga P Mohapatra
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

8.  Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures.

Authors:  V L Dawson; T M Dawson; G R Uhl; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 9.  HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists.

Authors:  S A Lipton
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

10.  Response of cell cycle proteins to neurotrophic factor and chemokine stimulation in human neuroglia.

Authors:  K L Jordan-Sciutto; B A Murray Fenner; C A Wiley; C L Achim
Journal:  Exp Neurol       Date:  2001-02       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.